文献速递心外重症与机械循环支持冠心病外科

肥胖与左心室辅助装置桥接对心脏移植候选者结局的影响:基于STS INTERMACS-OPTN/UNOS关联数据的分析

The impact of obesity and LVAD-bridging on heart transplant candidate outcomes: a linked STS INTERMACS - OPTN/UNOS data analysis.
PubMed 文献 · J Heart Lung Transplant · 2023-06-28

研究纳入2010-2019年STS INTERMACS与OPTN/UNOS关联的成年心脏移植候选者,比较左心室辅助装置(LVAD)桥接与非桥接策略按体重指数(BMI)分层的等待期、移植后及总体死亡率。结果显示LVAD桥接的肥胖候选者等待期死亡率高于非桥接肥胖候选者,移植后死亡率两组相似,但肥胖在两组均与死亡率增加相关。

要点

  • LVAD桥接候选者中肥胖比例高于非桥接候选者(37.3% vs 28.6%,p<0.001)。
  • LVAD桥接的超重(HR 1.18,95%CI 1.02-1.36)和肥胖(HR 1.35,95%CI 1.17-1.56)候选者等待期死亡率高于正常体重桥接候选者(HR 1.02,95%CI 0.88-1.19),交互作用p<0.001。
  • 移植后死亡率在各BMI分类中LVAD桥接与非桥接无统计学差异(交互作用p=0.26)。

核心结论

  • LVAD桥接的肥胖候选者等待期死亡率高于非桥接的肥胖候选者。
  • 移植后死亡率在LVAD桥接与非桥接患者中相似,但肥胖在两组均与死亡率增加相关。
  • 本研究可能有助于临床医生和肥胖的晚期心力衰竭患者进行决策。

研究设计与样本

  • 研究纳入2010-2019年在器官获取与移植网络/器官共享联合网络中登记等待心脏移植的成人,以及在胸外科医师协会/机械循环支持机构间登记数据库中接受持久LVAD作为移植或候选资格桥接的患者。
  • 共纳入11,216例LVAD桥接候选者和17,122例非桥接候选者。
  • 按登记或LVAD植入时的BMI分为体重不足(<18.5 kg/m2)、正常体重(18.5-24.99 kg/m2)、超重(25-29.99 kg/m2)和肥胖(≥30 kg/m2)。
  • 采用Kaplan-Meier分析和多变量Cox比例风险模型评估LVAD桥接与非桥接策略按BMI对等待期、移植后和总体死亡率(包括等待期和移植后死亡率)的影响。

主要发现

  • LVAD桥接候选者中肥胖比例高于非桥接候选者(37.3% vs 28.6%,p<0.001)。
  • 多变量分析显示,与正常体重桥接候选者(HR 1.02,95%CI 0.88-1.19)相比,超重(HR 1.18,95%CI 1.02-1.36)或肥胖(HR 1.35,95%CI 1.17-1.56)的LVAD桥接候选者等待期死亡率增加(交互作用p<0.001)。
  • 移植后死亡率在LVAD桥接与非桥接患者中各BMI分类间无统计学差异(交互作用p=0.26)。
  • 与非桥接患者相比,LVAD桥接的超重(HR 1.53,95%CI 1.39-1.68)或肥胖(HR 1.61,95%CI 1.46-1.78)患者总体死亡率呈非显著性分级增加(交互作用p=0.13)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited data integrating waitlist and postheart transplant (HT) mortality have evaluated outcomes of left ventricular assist device (LVAD)-bridged strategy vs no LVAD according to patient characteristics. We evaluated waitlist and post-HT mortality in LVAD-bridged vs nonbridged patients based on body mass index (BMI). METHODS: We included linked adults listed for HT in Organ Procurement and Transplant Network/United Network for Organ Sharing and patients receiving durable LVAD as bridge to HT or candidacy in Society of Thoracic Surgeons/Interagency Mechanical Circulatory Support databases (2010-2019). Using BMI at listing or LVAD implant, we categorized patients as underweight (<18.5 kg/m2), normal weight (18.5-24.99 kg/m2), overweight (25-29.99 kg/m2), and obese (≥30 kg/m2). Kaplan-Meier analysis and multivariable Cox proportional hazards models informed the effect of LVAD-bridged and nonbridged strategy by BMI on waitlist, post-HT, and overall mortality (including waitlist and post-HT mortality). RESULTS: Among 11,216 LVAD-bridged and 17,122 nonbridged candidates, bridged candidates were more frequently obese (37.3% vs 28.6%) (p < 0.001). Multivariable analysis indicated increased waitlist mortality in LVAD-bridged vs nonbridged with overweight (Hazard ratio (HR) 1.18, 95% confidence interval (CI) 1.02-1.36) or obesity (HR 1.35, 95%CI 1.17-1.56) in comparison to normal weight candidates (HR 1.02, 95%CI 0.88-1.19) (p-interaction < 0.001). Post-transplant mortality was not statistically different in LVAD-bridged vs nonbridged patients across BMI categories (p-interaction = 0.26). There was a nonsignificant graded increase in overall mortality in LVAD-bridged with overweight (HR 1.53, 95%CI 1.39-1.68) or obesity (HR 1.61, 95%CI 1.46-1.78) compared to nonbridged patients (p-interaction = 0.13). CONCLUSIONS: LVAD-bridged candidates with obesity had higher waitlist mortality compared to nonbridged candidates with obesity. Post-transplant mortality was similar in LVAD-bridged and nonbridged patients, but obesity remained associated with increased mortality in both groups. This study may aid clinicians and advanced heart failure patients with obesity in decision-making.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Alba AC, Kirklin JK, Cantor RS, et al. The impact of obesity and LVAD-bridging on heart transplant candidate outcomes: a linked STS INTERMACS - OPTN/UNOS data analysis. J Heart Lung Transplant. 2023. PMID: 37385418. doi:10.1016/j.healun.2023.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。